Sustainable Strategies for Preventing Antimicrobial Resistance in Agricultural and Livestock Systems

Antimicrobial resistance (AMR) is one of the major global health challenges of the twenty-first century, affecting humans, animals, agriculture, and the environment. AMR occurs when microorganisms such as bacteria, viruses, fungi, and parasites develop the ability to survive exposure to medicines that would normally inhibit or kill them. Although antimicrobial medicines are essential for treating infections, their inappropriate, excessive, or prolonged use can accelerate the development and spread of resistant microorganisms. Importantly, AMR is not limited to hospitals and human medicine. Agricultural and livestock production also plays an important role in the emergence, selection, and transmission of antimicrobial-resistant bacteria.

Antibiotics are widely used in farm animals to treat bacterial infections and, in some production systems, to prevent disease or control infections within groups of animals. When antibiotics are used, susceptible bacteria are eliminated, while bacteria with resistance mechanisms may survive and multiply. These resistant bacteria can spread between animals and potentially enter the wider environment through manure, soil, water, food products, and contact with farm workers. Resistant bacteria and resistance genes can therefore move between animals, humans, and environmental ecosystems, illustrating the interconnected nature of AMR under the One Health approach.

The agricultural use of antibiotics must therefore be carefully managed to protect both animal health and the effectiveness of antimicrobial medicines. However, reducing unnecessary antibiotic use does not mean compromising animal welfare or allowing preventable diseases to spread. Instead, it requires a shift toward prevention, early disease detection, improved farm management, and alternative approaches that can reduce the need for antibiotics. Responsible antimicrobial stewardship, including appropriate selection, dosage, and duration of antibiotic treatment under veterinary guidance, remains an important component of this approach.

Several alternatives and complementary strategies are being investigated and implemented in agricultural settings to mitigate the menace of AMR. Vaccination can prevent infectious diseases before they occur and consequently reduce the need for antibiotic treatment. Immunotherapeutics can support the animal’s immune response during periods of increased susceptibility to disease. Probiotics, prebiotics, and microbiome-based approaches aim to maintain beneficial microbial communities, particularly within the gastrointestinal tract, and may help limit the colonization and growth of pathogenic bacteria. Bacteriophage therapy offers another promising approach by using viruses that specifically target and destroy particular bacterial pathogens. Other emerging alternatives, including antimicrobial peptides and bacteriocins, are also being studied for their potential applications in animal health.

In addition to these biological alternatives, good agricultural practices and biosecurity are fundamental to reducing antimicrobial use. Appropriate housing, nutrition, sanitation, ventilation, stocking density, quarantine procedures, and early identification of disease can reduce infection pressure within herds and flocks. These measures can lower the frequency with which antibiotics are required while improving overall animal health and productivity.

Therefore, addressing AMR in agriculture requires more than simply replacing antibiotics with a single alternative. A comprehensive strategy combining disease prevention, vaccination, immune support, microbiome management, targeted therapies, responsible antibiotic use, and improved farm management can help reduce the selection and spread of resistant microorganisms while maintaining animal health, agricultural productivity, food safety, and environmental health.

One Health and its relevance to AMR in agriculture

One Health is an integrated and collaborative approach that recognizes that the health of humans, animals, plants, and the environment are closely interconnected. Rather than treating human health, animal health, and environmental health as separate areas, the One Health approach encourages professionals from different disciplines to work together to identify and manage health threats that can move between these interconnected systems. The concept is particularly important for diseases caused by microorganisms, AMR, food-borne infections, zoonotic diseases, and environmental contamination.

The health of humans and animals is closely linked because people and animals share many of the same environments, microorganisms, and resources (Figure 1). For example, infectious bacteria present in livestock can potentially be transmitted to humans through direct animal contact, contaminated food, water, or environmental pathways. At the same time, microorganisms and antimicrobial-resistant bacteria can move in the opposite direction, from humans to animals or from human-associated environments into agricultural systems. The environment acts as an important connecting pathway because soil, surface water, groundwater, manure, and wastewater can contain microorganisms and antimicrobial residues that influence the development and spread of resistance. One Health therefore emphasizes understanding these interactions rather than addressing each sector independently.

This interconnectedness is particularly evident in AMR. AMR occurs when microorganisms develop mechanisms that allow them to survive exposure to antimicrobial medicines that would normally inhibit or kill them. Although resistance can arise naturally through genetic variation and mutation, the use and misuse of antimicrobials can accelerate the selection of resistant microorganisms. Antibiotics used in livestock production create selective pressure on bacterial populations. Susceptible bacteria may be eliminated, while resistant bacteria survive and multiply. These bacteria can subsequently spread among animals and potentially move beyond the farm environment.

Agriculture is therefore an important component of the One Health response to AMR. Antibiotics are essential for treating bacterial infections in farm animals and protecting animal health, but unnecessary or inappropriate use can contribute to the selection of resistant bacteria. Resistant microorganisms may be disseminated through animal manure, contaminated soil and water, food products, farm equipment, and direct contact between animals and humans. Agricultural workers can potentially encounter resistant bacteria through their occupational exposure, while consumers may be exposed through contaminated food if appropriate food-safety measures are not followed.

The environmental dimension of agricultural AMR is equally important. Manure from treated animals can contain resistant bacteria, resistance genes, and antimicrobial residues. When manure is applied to agricultural land, these materials can enter soil and potentially reach water systems through runoff or leaching. This creates opportunities for resistance determinants to persist, interact with other microorganisms, and potentially spread through environmental microbial communities. Consequently, managing AMR requires attention not only to how antibiotics are prescribed and administered but also to how agricultural waste and contaminated environments are managed.

A One Health approach to AMR in agriculture therefore involves collaboration among veterinarians, farmers, physicians, microbiologists, environmental scientists, public-health professionals, policymakers, and other stakeholders. Key strategies include responsible antibiotic use, vaccination, improved animal husbandry, effective biosecurity, disease surveillance, good hygiene, appropriate manure management, and the development of alternatives to antibiotics. Monitoring antimicrobial use and resistance patterns across humans, animals, food, and the environment can also help identify emerging threats and guide interventions.

One Health provides a framework for understanding AMR as a shared and interconnected problem rather than an issue belonging exclusively to human medicine or veterinary medicine. In agricultural settings, protecting animal health while minimizing unnecessary antimicrobial exposure can help reduce the emergence and dissemination of resistant bacteria. Integrating agricultural practices with human health and environmental protection is therefore essential for preserving the effectiveness of antibiotics and safeguarding health across the entire One Health system.

Vaccination and disease prevention as a foundation for AMR control in agriculture

AMR in agricultural systems is closely linked to the frequency and manner in which antimicrobial agents are used in livestock and poultry production. A practical strategy for addressing this challenge is to shift disease management from a predominantly antibiotic-treatment-oriented model toward one centered on prevention, preparedness, and population health. Vaccination represents one of the most important components of this transition because it can reduce the occurrence of infectious diseases and, consequently, the circumstances in which antibiotics are required.

Vaccination functions as an upstream intervention against antimicrobial use. Rather than eliminating bacteria after infection has been established, vaccines prepare the animal’s immune system to recognize and respond to specific pathogens more effectively. By lowering the incidence, severity, or duration of vaccine-preventable infections, vaccination can reduce the likelihood that animals will require therapeutic antimicrobial treatment. This is particularly relevant when an initial viral or other infectious disease weakens animals and creates conditions for subsequent bacterial infections. Preventing the primary disease can therefore interrupt a chain of events that might otherwise culminate in antibiotic administration.

The value of vaccination becomes even more pronounced in intensive livestock and poultry production, where animals are often maintained in groups and infectious agents can move rapidly through a population. A well-designed vaccination program can provide population-level protection, limiting opportunities for pathogens to circulate and reducing the overall infectious burden within a herd or flock. Beyond protecting individual animals, this collective protection can contribute to more stable production systems by reducing disease-associated mortality, impaired growth, production losses, and repeated antimicrobial interventions.

From an AMR perspective, reducing unnecessary antibiotic exposure is particularly important because antimicrobial use creates selective pressure that can favor bacteria carrying resistance traits. When susceptible bacteria are eliminated while resistant organisms survive, resistant populations may become more prominent and can subsequently spread between animals, farm environments, and, in some circumstances, other ecological compartments. Vaccination does not directly eliminate antimicrobial-resistant bacteria, but by reducing the need for antimicrobial treatment, it can decrease one of the major drivers that facilitates the emergence and amplification of resistance.

Vaccination should, however, be regarded as part of a multilayered disease-prevention framework, rather than as a stand-alone solution. Farm-level biosecurity can reduce the introduction of pathogens through animals, personnel, equipment, vehicles, feed, and other potential pathways. Appropriate cleaning and disinfection practices can further limit environmental contamination. Similarly, maintaining adequate nutrition, access to clean water, suitable ventilation, appropriate stocking densities, and comfortable housing conditions can strengthen animal resilience and reduce susceptibility to disease.

Another important component is early disease surveillance. Regular observation of animal health, production performance, and abnormal clinical signs can allow emerging problems to be identified before they develop into widespread outbreaks. When combined with veterinary guidance, diagnostic testing, and targeted vaccination schedules, surveillance can support more precise decisions about when antimicrobial intervention is genuinely necessary.

Vaccination and preventive husbandry can help transform AMR management from a reactive process into a proactive agricultural health strategy. By preventing infections before they require treatment and creating production environments in which disease is less likely to spread, these measures can reduce antimicrobial dependence while supporting animal health, productivity, and the long-term sustainability of livestock production.

Immunotherapeutics and strengthening host immunity in agricultural systems

The control of AMR in agriculture requires approaches that reduce the frequency with which antibiotics are needed rather than relying exclusively on the development of new antimicrobial drugs. One promising direction is immunotherapeutics, which aim to enhance, regulate, or redirect the animal’s own immune defenses against infectious agents. Instead of directly eliminating bacteria through antimicrobial compounds, these interventions seek to improve the host’s capacity to recognize pathogens, restrict their multiplication, and eliminate infections through coordinated immune responses. This shift from pathogen-directed treatment toward host-directed disease managementcould provide an important component of antibiotic-sparing strategies in livestock production.

The immune competence of agricultural animals is influenced by genetics, nutrition, age, environmental conditions, stress, and exposure to pathogens. Animals may experience periods of increased susceptibility when physiological demands or management practices temporarily compromise immune function. Weaning, transportation, mixing of animals, changes in housing, parturition, and sudden dietary transitions can create conditions in which normally manageable microorganisms become pathogenic. During such windows of vulnerability, immunotherapeutic interventions could potentially reinforce host defenses before infection becomes established. Rather than waiting until clinical disease requires antibiotic treatment, the objective is to increase the animal’s biological resilience at critical points in the production cycle.

Potential immunotherapeutic approaches include immune stimulants, immunomodulatory compounds, recombinant immune mediators, and targeted biological preparations designed to enhance particular components of innate or adaptive immunity. For example, stimulating innate immune mechanisms may improve the early recognition of invading microorganisms and accelerate the recruitment of immune cells to infected tissues. Other interventions may support antigen-specific immune responses, enabling animals to mount a more efficient defense following previous exposure or vaccination. The advantage of such approaches is that they can potentially complement existing preventive measures without placing the same direct selective pressure on bacterial populations as conventional antibiotics.

However, immunotherapeutics should not be viewed as universally applicable replacements for antibiotics. Immune enhancement must be appropriately calibrated, because excessive or poorly regulated immune activation may contribute to inflammation, tissue damage, reduced productivity, or metabolic costs. The biological response can also vary according to species, age, health status, pathogen, production system, and environmental conditions. Identifying the appropriate intervention, dosage, delivery route, and timing is critical for achieving beneficial immune modulation without creating undesirable physiological effects.

From an AMR perspective, the greatest value of immunotherapeutics may arise when they are integrated into a layered disease-prevention framework. Improved immune resilience can work alongside vaccination, optimized nutrition, biosecurity, environmental management, and early disease detection. By reducing the probability that animals progress from exposure to clinically significant infection, these measures can decrease the number of situations in which therapeutic antibiotics are required. Fewer antibiotic treatments mean fewer opportunities for susceptible bacterial populations to be eliminated while resistant variants survive and proliferate.

Future agricultural applications may therefore move toward precision immunomodulation, in which interventions are selected according to the animal’s physiological state, production stage, immune profile, and pathogen exposure risk. Such an approach could transform disease management from reactive antibiotic treatment toward proactive maintenance of host resilience. Although substantial research is still required to establish efficacy, safety, cost-effectiveness, and scalability, strengthening host immunity represents a scientifically distinct pathway for reducing antibiotic dependence and supporting long-term AMR management in livestock production.

Probiotics, prebiotics, and microbiome management in agricultural livestock

The intestinal microbiome is increasingly recognized as an important biological component of livestock health and as a potential tool for reducing dependence on antibiotics. Rather than relying exclusively on antimicrobial drugs to control bacterial disease, microbiome-based strategies aim to create intestinal conditions in which beneficial microorganisms are supported and opportunistic pathogens are less able to establish themselves. This approach is particularly relevant to AMR because reducing unnecessary antibiotic exposure can decrease the selective pressure that favors resistant bacterial populations. Some potential approaches include:

Probiotics as microbial stabilizers: Probiotics are live microorganisms administered in adequate quantities to support animal health. Commonly investigated groups include Lactobacillus, Bifidobacterium, Bacillus, and yeast-based preparations. In livestock, these organisms may influence intestinal conditions through several mechanisms, including production of organic acids and antimicrobial compounds, competition for nutrients and attachment sites, and modulation of host immune responses. Their value therefore extends beyond simply replacing antibiotics; they can contribute to maintaining an intestinal environment that is less favorable to pathogenic bacteria.

Competitive exclusion of pathogens: A diverse and functional microbial community can act as a biological barrier against organisms such as Salmonella, Escherichia coli, and Clostridium species. Beneficial microorganisms may occupy ecological niches before pathogens can establish themselves, limiting their proliferation and persistence. This phenomenon, known as competitive exclusion, provides an important rationale for microbiome-directed interventions in intensive animal production systems, particularly during periods of increased disease susceptibility.

Prebiotics as microbiome-directed nutrition: Prebiotics are selectively utilized substrates that promote the activity or abundance of beneficial microorganisms already present in the gastrointestinal tract. In animal production, compounds such as certain fermentable fibers, oligosaccharides, and resistant carbohydrates can be incorporated into feed formulations. Their fermentation may generate metabolites such as short-chain fatty acids, which can influence intestinal pH, epithelial integrity, nutrient utilization, and microbial composition. Consequently, prebiotic supplementation represents a nutritional strategy for shaping the microbial ecosystem rather than directly eliminating bacteria.

Synbiotics and integrated microbial interventions: Combining probiotics with compatible prebiotics, often described as a synbiotic approach, may provide complementary benefits by supplying beneficial microorganisms alongside substrates that support their persistence and activity. Such interventions could be incorporated into broader herd-health programs involving optimized nutrition, vaccination, hygiene, and disease surveillance. This integrated strategy may be more sustainable than treating recurring infections solely through antimicrobial administration.

Microbiome management for AMR mitigation: Antibiotic exposure can alter the composition and ecological balance of the gut microbiota, potentially creating conditions that favor resistant organisms or facilitate the persistence and dissemination of antimicrobial-resistance genes. Maintaining microbial stability through nutritional and management interventions may therefore contribute indirectly to AMR control. The objective is not necessarily to eliminate pathogens completely, but to maintain a microbial ecosystem capable of resisting pathogen expansion and supporting animal resilience.

Despite promising findings, microbiome-based interventions remain highly context-dependent. Their performance can vary according to animal species, age, genetics, diet, housing conditions, environmental exposure, and the composition of the existing microbiota. Commercial probiotic products may also differ in strain identity, viability, dose, and stability. Future research should therefore move beyond generic probiotic supplementation toward strain-specific, precision microbiome management, supported by metagenomics, metabolomics, and functional characterization. Identifying which microbial communities and metabolites are associated with disease resistance could enable more predictable interventions and strengthen the role of microbiome management as a component of sustainable AMR reduction in agriculture.

Bacteriophage therapy and other targeted alternatives in agricultural settings

The increasing prevalence of AMR in agricultural environments has intensified the search for interventions that can control bacterial infections without depending exclusively on conventional antibiotics. Among the most promising approaches is bacteriophage therapy, which exploits naturally occurring viruses known as bacteriophages, or phages, that infect particular bacterial hosts. Unlike many antibiotics, which may affect a broad range of microorganisms, phages can exhibit a high degree of bacterial specificity. This characteristic creates an opportunity to suppress pathogenic organisms while potentially preserving beneficial members of the animal microbiota.

In livestock production, phages could be developed against important bacterial pathogens associated with diseases of poultry, cattle, pigs, and other farmed animals. Their application may involve administration through drinking water, feed, topical preparations, or other delivery systems, depending on the pathogen and infection site. A particularly attractive feature of phage-based interventions is their capacity to multiply at the site where susceptible bacteria are present. Phages may function differently from conventional antimicrobial compounds, with their activity closely linked to the presence of their bacterial host. This could provide a more focused strategy for controlling infection and reducing unnecessary disruption of microbial communities.

However, phage therapy is not without biological and operational challenges. Phages are generally strain-specific, meaning that a phage capable of controlling one bacterial isolate may have little or no activity against another isolate of the same species. Therefore, successful implementation may require rapid pathogen identification and characterization before treatment. This requirement presents difficulties in agricultural systems, where large numbers of animals may be affected simultaneously and laboratory-based diagnostics can be time-consuming or costly. Furthermore, bacterial populations can evolve mechanisms that prevent phage attachment, replication, or successful infection, creating the possibility of phage resistance.

One strategy for overcoming this limitation is the development of phage cocktails, consisting of several phages with complementary host ranges. Combining different phages can broaden antibacterial coverage and make it more difficult for bacteria to escape treatment through a single resistance mechanism. Phage formulations may also be periodically modified as pathogen populations change. Such adaptability is particularly relevant to intensive farming systems, where bacterial populations can evolve rapidly under strong environmental and antimicrobial selection pressures.

Beyond bacteriophages, several other targeted biological approaches are gaining attention. Antimicrobial peptides (AMPs) can damage bacterial membranes or interfere with essential cellular processes, while bacteriocins antibacterial compounds produced by certain microorganisms can inhibit closely related bacterial species. These molecules may provide opportunities for pathogen-specific control with potentially lower ecological disruption than broad-spectrum antibiotics. Their stability, production cost, delivery, and performance under farm conditions, however, remain important considerations.

Another emerging direction is precision microbiome management, which seeks to manipulate microbial communities so that beneficial organisms suppress pathogens through competition, metabolite production, or modification of the intestinal environment. Rather than directly killing bacteria, this strategy aims to make the host environment less favorable for pathogen establishment. Taken together, phages, antimicrobial peptides, bacteriocins, and microbiome-directed technologies represent a shift from indiscriminate bacterial elimination toward precision antimicrobial management. Their future contribution to AMR control will depend on improving delivery systems, understanding resistance evolution, demonstrating consistent field efficacy, and integrating these technologies into broader disease-prevention programs.

Improved farm management and biosecurity in AMR control

AMR in agricultural systems cannot be addressed through antibiotic stewardship alone. The conditions under which animals are raised strongly influence their exposure and susceptibility to infectious diseases. Improving farm management and strengthening biosecurity can serve as a preventive barrier against AMR, reducing the frequency of infections that would otherwise require antimicrobial intervention. Rather than relying on antibiotics after disease has become established, farms can adopt management practices that interrupt the transmission cycle at multiple points. Some of the approaches adopted include: 

Enhanced hygiene and environmental sanitation: Regular cleaning and disinfection of animal housing, feeding equipment, water systems, transport facilities, and other high-contact areas can reduce the environmental burden of pathogenic microorganisms. Particular attention should be given to manure accumulation, contaminated bedding, and shared equipment, which can act as reservoirs for infectious agents. Establishing clearly defined sanitation routines can therefore reduce opportunities for both susceptible and resistant bacteria to circulate within production systems.

Optimized housing and animal welfare: Poor ventilation, excessive stocking density, inadequate temperature control, and poor-quality bedding can increase physiological stress and compromise animals’ natural defenses. Improving airflow, maintaining appropriate stocking densities, providing adequate space, and ensuring suitable environmental conditions can reduce disease pressure. Good-quality feed and reliable access to clean water are similarly important because nutritional deficiencies and dehydration can weaken host resilience and increase vulnerability to infection.

Strategic quarantine and animal movement control: Newly purchased, returning, or transported animals may introduce unfamiliar pathogens, including antimicrobial-resistant organisms, into established populations. A structured quarantine period allows animals to be observed and, where appropriate, tested before they are integrated into the main herd or flock. Separating clinically ill animals from healthy groups can further restrict transmission. Controlling unnecessary movement of animals, personnel, equipment, and vehicles between production units also reduces opportunities for resistant microorganisms to spread.

Early detection and precision monitoring: Continuous observation of animal health can enable farmers and veterinarians to identify abnormal behavior, reduced feed intake, respiratory symptoms, diarrhea, changes in production, or other early indicators of disease. Digital monitoring systems, automated sensors, and farm health records can increasingly support this process by identifying deviations from normal patterns. Early recognition allows targeted veterinary intervention before an infection becomes widespread, potentially reducing the need for large-scale or prolonged antimicrobial treatment.

Integrated disease-prevention planning: Biosecurity should function as a coordinated system rather than a collection of isolated practices. Farms can develop risk-based prevention plans that identify major routes of pathogen entry and transmission and establish specific control measures for each. Collaboration between farmers, veterinarians, animal-health professionals, and other stakeholders can strengthen surveillance and encourage responsible antimicrobial decision-making.

These measures shift agricultural disease management from a treatment-dependent model toward prevention-oriented production. By reducing pathogen exposure, strengthening animal resilience, and detecting disease at an earlier stage, improved farm management can decrease the frequency of antibiotic use. This reduction in antimicrobial exposure is important because repeated or inappropriate antibiotic use creates selective pressure that favors the survival and dissemination of resistant bacteria. Effective farm management and biosecurity are not merely complementary agricultural practices; they are fundamental components of a broader strategy to contain AMR and preserve the effectiveness of existing antimicrobials.

References

Adegbole, C., Seilkhanova, T., Bajwa, M. R., & Smith, R. L. (2025). Unlocking farm-level antimicrobial resistance: A qualitative study of researchers’ experiences and challenges. Frontiers in Veterinary Science, 12, 1691572.

Elbehiry, A., & Marzouk, E. (2025). From farm to fork: Antimicrobial-resistant bacterial pathogens in livestock production and the food chain. Veterinary Sciences, 12(9), 862.

Enshaie, E., Nigam, S., Patel, S., & Rai, V. (2025). Livestock antibiotics use and antimicrobial resistance. Antibiotics, 14(6), 621.

Food and Agriculture Organization of the United Nations. (n.d.). Antimicrobial resistance in animal production.

Jadeja, N. B., & Worrich, A. (2022). From gut to mud: Dissemination of antimicrobial resistance between animal and agricultural niches. Environmental Microbiology, 24, 3290–3306.

Martins, S. B., Afonso, J. S., Fastl, C., Huntington, B., & Rushton, J. (2024). The burden of antimicrobial resistance in livestock: A framework to estimate its impact within the Global Burden of Animal Diseases programme. One Health, 19, 100917.

Panicker, A., Changaroth, A., Gangadharan, S. V., et al. (2025). From farms to homes: Navigating antimicrobial resistance landscapes from livestock to humans. One Health Advances, 3, 20.

Thanner, S., Drissner, D., & Walsh, F. (2016). Antimicrobial resistance in agriculture. mBio, 7(2).

Trinchera, M., De Gaetano, S., Sole, E., Midiri, A., Silvestro, S., Mancuso, G., Catalano, T., & Biondo, C. (2025). Antimicrobials in livestock farming and resistance: Public health implications. Antibiotics, 14(6), 606.

Venkateswaran, N., Swetschinski, L. R., Fastl, C., et al. (2024). Using priorities between human and livestock bacterial antimicrobial resistance (AMR) to identify data gaps in livestock AMR surveillance. BMC Infectious Diseases, 24, 1027.